Research project
Comparative study between an oral formulation of the phytocannabinoid derivative VCE-003.2 (EHP-102) and L-DOPA/Benserazide in Parkinson’s disease using 6-hydroxydopamine-lesioned mice
date_range
Duration: from 01 January 2022 to 31 December 2022
(12 months)
Researchers
JOSÉ JAVIER
FERNÁNDEZ RUIZ
Leader